| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 09/13/2001 | WO2001066133A1 Leptin-resistance ameliorating agents |
| 09/13/2001 | WO2001066107A2 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases |
| 09/13/2001 | WO2001066085A2 Micellar pharmaceutical compositions for buccal and pulmonary application |
| 09/13/2001 | WO2001029178A3 Epo primary response gene 1, eprg1 |
| 09/13/2001 | US20010021719 2-phenyl-1- [4- (2-aminoethoxy) - benzyl] - indoles as estrogenic agents |
| 09/13/2001 | US20010021401 Process for the preparation of an herbal-therapeutic product extracted from the pulp of a species eugenia jambolana |
| 09/13/2001 | CA2401946A1 Rfrp-containing prolactin secretion regulatory agent |
| 09/13/2001 | CA2401323A1 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases |
| 09/13/2001 | CA2400401A1 Novel natural polymer-based material with improved properties for use in human and veterinary medicine and the method of manufacturing such |
| 09/13/2001 | CA2399921A1 Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies |
| 09/12/2001 | EP1132388A2 Hexahydropyrazolo[4,3-c]pyridine metabolites |
| 09/12/2001 | EP1132091A1 Treatment for diabetes |
| 09/12/2001 | EP1131445A1 Human phospholipases |
| 09/12/2001 | EP1131428A2 Immunoglobulin superfamily proteins |
| 09/12/2001 | EP1131340A2 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis |
| 09/12/2001 | EP1131327A1 Prostaglandin conjugates for treating or preventing bone disease |
| 09/12/2001 | EP1131083A1 Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
| 09/12/2001 | EP1131065A2 Utilisation of dialkylfumarates |
| 09/12/2001 | EP1131064A2 Use of benzoylguanidines for the treatment of non-insulin-dependent diabetes mellitus |
| 09/12/2001 | EP1131061A1 Agent for lowering prolactin |
| 09/12/2001 | EP1131052A1 Vaginally administrable progesterone-containing tablets and method for preparing same |
| 09/12/2001 | EP0883596B1 Fluorinated propranolol and related methods |
| 09/12/2001 | EP0880366B1 Skin-adhering pharmaceutical preparation, in particular transdermal therapeutic system for the release of 17-beta-estradiol to the human organism |
| 09/12/2001 | CN1312803A Novel benzopykan or thiobenzopyran derivatives |
| 09/12/2001 | CN1070849C Enzyme inhibitors |
| 09/11/2001 | US6288126 Biphenyl compounds and use thereof as oestrogenic agents |
| 09/11/2001 | US6288107 Sulfatase inhibitors |
| 09/11/2001 | US6288090 Pharmaceutical composition |
| 09/11/2001 | US6288078 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 09/11/2001 | US6288051 Estrogen-dependent breast cancer treatment |
| 09/11/2001 | US6288050 Steroid sulfatase inhibitors and methods for making and using the same |
| 09/07/2001 | WO2001064669A1 Pyrazole ether derivatives as anti-inflammatory/analgesic agents |
| 09/07/2001 | WO2001064665A1 Chroman derivatives as estrogenic compounds |
| 09/07/2001 | WO2001064634A1 Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof |
| 09/07/2001 | WO2001064633A1 Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof |
| 09/07/2001 | WO2001064632A1 Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same |
| 09/07/2001 | WO2001064236A2 METHODS FOR TREATING FSH RELATED CONDITIONS WITH GnRH ANTAGONISTS |
| 09/07/2001 | WO2001064227A2 Androgenic activity of eucommia ulmoides extracts |
| 09/07/2001 | WO2001010383A3 Caspase inhibitors and uses thereof |
| 09/07/2001 | WO2000054763A3 Pharmaceutical compositions comprising polymorphic forms of dehydroepiandrosterone |
| 09/07/2001 | WO2000047603A9 16-hydroxyestratrienes as selective estrogens |
| 09/07/2001 | CA2401697A1 Pyrazole ether derivatives as anti-inflammatory/analgesic agents |
| 09/07/2001 | CA2401022A1 Methods for treating fsh related conditions with gnrh antagonists |
| 09/07/2001 | CA2400138A1 Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof |
| 09/07/2001 | CA2400116A1 Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same |
| 09/06/2001 | US20010020016 Formulation |
| 09/05/2001 | EP1129091A2 Crf receptor antagonists and methods relating thereto |
| 09/05/2001 | EP1129072A2 N-substituted azacycles, their preparation and their use as orl-1 receptor ligands |
| 09/05/2001 | EP1128813A1 An inhalation system |
| 09/05/2001 | EP0862556B1 17-alkyl-7-substituted-4-aza steroid derivatives |
| 09/05/2001 | CN1311767A Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders |
| 09/05/2001 | CN1311686A Pulmonary delivery of active agents |
| 09/05/2001 | CN1311683A Use of biogenic estrogen sulfamates for hormone replacement therapy |
| 09/05/2001 | CN1311682A Pharmaceutical compositions and uses for androst-5-ene-3beta, 17 beta-diol |
| 09/04/2001 | US6285537 Stress-follower circuit configuration |
| 09/04/2001 | US6284887 Process for preparing carboxamido-4-azasteroids |
| 09/04/2001 | US6284872 Tendon-inducing compositions |
| 09/04/2001 | US6284749 Mixture of fungicide with chelate compound |
| 09/04/2001 | US6284268 Cyclosporin, synergistic |
| 08/30/2001 | WO2001062923A2 Transporters and ion channels |
| 08/30/2001 | WO2001062789A1 Human polynucleotides, polypeptides, and antibodies |
| 08/30/2001 | WO2001062774A2 Purified lh |
| 08/30/2001 | WO2001062757A1 Novel compounds |
| 08/30/2001 | WO2001062741A1 Tetrahydronaphtalene derivatives and their use |
| 08/30/2001 | WO2001062740A1 Mibefradil analogues and their use |
| 08/30/2001 | WO2001062729A1 Novel compounds |
| 08/30/2001 | WO2001062728A1 Novel compounds |
| 08/30/2001 | WO2001062718A1 Benzamide derivative and use thereof |
| 08/30/2001 | WO2001062312A1 Foam-forming wound dressing |
| 08/30/2001 | WO2001062297A1 Compositions and methods for enhancing drug delivery across biological membranes and tissues |
| 08/30/2001 | WO2001062270A2 Method for treating hashimoto's thyroiditis |
| 08/30/2001 | WO2001062269A2 Use of neurotoxins for treating parathyroid disorders |
| 08/30/2001 | WO2001062266A2 Use of dpp-iv inhibitors for the treatment of diabetes |
| 08/30/2001 | WO2001012606A3 Tetrahydroquinoline derivatives having retinoid-like biological activity |
| 08/30/2001 | WO2000040733A9 Human cyclic nucleotide pdes |
| 08/30/2001 | CA2401113A1 Transporters and ion channels |
| 08/30/2001 | CA2400435A1 Novel compounds |
| 08/30/2001 | CA2400434A1 Novel compounds |
| 08/30/2001 | CA2400293A1 Novel compounds |
| 08/30/2001 | CA2400099A1 Compositions and methods for enhancing drug delivery across biological membranes and tissues |
| 08/30/2001 | CA2399211A1 Foam-forming wound dressing |
| 08/30/2001 | CA2398275A1 Human polynucleotides, polypeptides, and antibodies |
| 08/29/2001 | EP1127882A1 Tetrazole compounds as thyroid receptor ligands |
| 08/29/2001 | EP1127573A1 Compostitions and methods for treating osteoporosis |
| 08/29/2001 | EP1127071A1 Compounds with growth hormone releasing properties |
| 08/29/2001 | EP1127058A1 Pyrazolopyridine derivatives as selective cox-2 inhibitors |
| 08/29/2001 | EP1127051A2 Tricyclic pyrazole derivatives |
| 08/29/2001 | EP1126865A2 Methods and compositions for treating or preventing peripheral neuropathies |
| 08/29/2001 | EP1126858A1 Production of a biological factor and creation of an immunologically privileged environment using genetically altered sertoli cells |
| 08/29/2001 | EP1126854A1 Benzoazepines and analogs thereof useful as growth hormone secretagogues |
| 08/29/2001 | EP1126849A1 Heterocyclic potassium channel inhibitors |
| 08/29/2001 | EP1126836A1 Benzamide potassium channel inhibitors |
| 08/29/2001 | EP0828758B1 Chimeric fatty body-pro-grf analogs with increased biological potency |
| 08/29/2001 | CN1310705A Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation |
| 08/29/2001 | CN1310615A Estradiol-containing patch for transdermal administration of hormones |
| 08/28/2001 | US6281241 Use of melatonin for the treatment of androgenetic alopecia |
| 08/28/2001 | US6281205 Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 08/28/2001 | US6281204 19-nor steroids having a thiocarbonated chain in position 11beta, their preparation process and the intermediates of this process, and the intermediates of this process, their use as medicaments and compositions |
| 08/28/2001 | US6280777 Soya extract, process for its preparation and pharmaceutical composition |
| 08/23/2001 | WO2001061008A2 Polypeptides and nucleic acids encoding same |